Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 361 AL 375

Microglial perturbation in heavy metal-induced neuroinflammation and neurodegeneration: mechanisms, phenotypic plasticity, and therapeutic prospects

Oria RS, Esomonu UG, Sunday KI, Oge PA.

Biometals. 2026 Oct 28. doi: 10.1007/s10534-026-00895-7. Online ahead of print.

Comparative analysis of single and dual sgRNA CRISPR/Cas9 ribonucleoprotein strategies for efficient Park7 gene editing in primary mouse embryonic fibroblasts

Suryadevara L, Srinivas V, Barathidasan R, Mhaske ST, Naik RR, Gupta MK, Pramod RK.

Mol Biol Rep. 2026 Oct 29;53(1):1843. doi: 10.1007/s11033-026-13053-6.

The Role of Mediterranean, MIND, and Ketogenic Diets in the Management of Parkinson's Disease

Şahin Anılgan İN, Yıldıran H.

Curr Nutr Rep. 2026 Oct 28;15(1):89. doi: 10.1007/s13668-026-00813-w.

Mitochondrial Dysfunction as a Convergent Mechanism of α-Synuclein Toxicity: A Systematic Review of In Vitro Fibrillar Models

Al Tbeishat H, Ward DG, Pienaar IS, Elsworthy RJ.

Mol Neurobiol. 2026 Oct 28;63(1):998. doi: 10.1007/s12035-026-06287-9.

AI-Driven Discovery and Delivery Systems for Anti-Parkinsonian Agents.

Tiwari PC, Kartik S, Rohilla K, Chaudhary MJ, Pal R, Nath R

J Drug Target. 2026:1-45. doi: 10.1080/1061186X.2026.2756474.

Scutellarin as a multi-target neuroprotective agent: Analytical evidence, pharmacokinetic insights and translational strategies across neurodegenerative disorders

Xiao Y, Li XY, Ding H, Wen JX, Dai YX, Zhang YJ, Li SP, Wang YX, Zhou HJ, Zhang BM, Huang ZY, Lou HK, Wang YJ, Cui XJ, Wang HS, Yao M.

Pharmacol Res. 2026 Oct 29;234:109714. doi: 10.1016/j.phrs.2026.109714. Online ahead of print.

The pathological roles of intrinsically disordered proteins in lysosomal acidification dysfunction in neurodegenerative diseases

Abd-ElRaouf K, Murphy DT, Cheong LYT, Zeng J, Lo CH.

Transl Neurodegener. 2026 Oct 28;15(1):58. doi: 10.1186/s40035-026-00591-z.

Post-traumatic Hypertrophic Olivary Degeneration with Palatal Myoclonus-A Case Report

Bailey K, Hanson JT, Khalil S.

J Child Neurol. 2026 Oct;41(9):1344-1347. doi: 10.1177/08830738261417414. Epub 2026 Mar 3.

Mental Health and Wellness Following Large-Scale Catastrophic Events: The Role of the Pediatric Clinician

Perry BD.

Pediatr Clin North Am. 2026 Oct;73(5):985-996. doi: 10.1016/j.pcl.2026.04.008. Epub 2026 Jul 28.

Transient Postoperative Myoclonus Following Hypothermic Circulatory Arrest

Lingle B, Lambert T, Claypoole S, Dev H, Douglas H, Nossaman BD.

Ochsner J. 2026 Fall;26(3):245-246. doi: 10.31486/toj.25.0085.

Parkinsonism and Cortical Myoclonus Due to Cryptococcal Encephalitis

Angeloni B, Gosse P, Callister M, Ganos C.

Mov Disord Clin Pract. 2026 Oct 5:10.1002/mdc3.70859. doi: 10.1002/mdc3.70859. Online ahead of print.

Chronic posthypoxic myoclonus: Lance-Adams syndrome

Dean E, Hussain S, Garstang E, Woodcock T, Harris J, Moriarty M, Lee GC.

BMJ Case Rep. 2026 Oct 6;19(10):e270605. doi: 10.1136/bcr-2025-270605.

Palatal myoclonus in tuberculous meningitis: a case report

Nigam H, Chakraborty R, Verma R, Khetan A, Mishra AP, Kamble A.

Encephalitis. 2026 Oct;6(4):113-115. doi: 10.47936/encephalitis.2026.00094. Epub 2026 Oct 8.

Tremor or myoclonus? A practical clinical approach to distinguishing two common hyperkinetic movement disorders

Puisieux S, Frismand S.

Rev Neurol (Paris). 2026 Nov;182(9):799-805. doi: 10.1016/j.neurol.2026.09.006. Epub 2026 Oct 10.

Executive Summary of the Clinical Practice Guideline on Tinnitus Update

Adams ME, Cramer JD, Tunkel DE, Lee VS, Bourgeois JA, Eshraghi AA, Fagelson MA, White KB, Juliano AF, Kim H, Kuzbyt B, Lynch PA, Miller M, Noonan KY, Roehm PC, Schaffer SR, Sherlock LP, Steenerson KK, Wallhagen M, Zaugg TL, Akrami Z.

Otolaryngol Head Neck Surg. 2026 Oct;175(4):739-756. doi: 10.1002/ohn.70418.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias